San Diego, CA, United States of America

Veli-Pekka Jaakola

This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Veli-Pekka Jaakola. Retrieved from https://idiyas.com/inventor/veli-pekka-jaakola

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Veli-Pekka Jaakola: Innovator in Therapeutic Development

Introduction

Veli-Pekka Jaakola is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutics targeting human Aadenosine receptor proteins. His work is instrumental in advancing our understanding of G-protein coupled receptors.

Latest Patents

Jaakola holds a patent that provides the structure of human Aadenosine receptor protein bound to an antagonist. This invention outlines methods of utilizing one or more binding sites and other features of this receptor to develop new therapeutics. His innovative approach has the potential to lead to breakthroughs in medical treatments.

Career Highlights

Veli-Pekka Jaakola is affiliated with The Scripps Research Institute, where he conducts his research. His work has garnered attention for its implications in drug development and therapeutic applications. He has established himself as a key figure in the scientific community.

Collaborations

Some of his notable coworkers include Raymond C. Stevens and Michael Allen Hanson. Their collaborative efforts contribute to the advancement of research in the field of biochemistry and therapeutic development.

Conclusion

Veli-Pekka Jaakola's contributions to the field of biochemistry and his innovative patent work highlight his role as a leading inventor in therapeutic development. His research continues to pave the way for new medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…